Epimerox

Epimerox is an experimental broad-spectrum antibiotic compound being developed by scientists at the Rockefeller University and Astex Pharmaceuticals. It is a small molecule inhibitor compound that blocks the activity of the enzyme UDP-N-acetylglucosamine 2-epimerase, an epimerase enzyme that is called 2-epimerase for short.
Wikipedia contributors, "Epimerox", Wikipedia, revision 1370377964, retrieved 20 November 2026, source, CC BY-SA 4.0.